These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3913223)

  • 1. [Kidney function and bacteriological and histological research in the therapy of experimental E. coli pyelonephritis using trimethoprim-sulfamethoxazole (TMP-SMO)].
    Hagemann I; Briedigkeit H; Strangfeld D; Precht K; Ditscherlein G; Puls U; Neubrandt C; Pietsch R; Kruse I
    Z Urol Nephrol; 1985 Dec; 78(12):681-8. PubMed ID: 3913223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bacteriologic, histologic and functional studies of the kidney in 5 days' therapy of experimental E. coli pyelonephritis with gentamycin. Comparison with 9 days' therapy].
    Hagemann I; Briedigkeit H; Strangfeld D; Ditscherlein G; Schürer M; Pietsch R; Kruse I; Camu A; Blank W
    Z Urol Nephrol; 1985 Nov; 78(11):625-31. PubMed ID: 3913218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental cystitis in the rat and the therapeutic effect of a single dose of fosfomycin trometamol].
    Dubini F; Riviera L; Visconti A
    Ann Ist Super Sanita; 1987; 23(4):803-7. PubMed ID: 3330644
    [No Abstract]   [Full Text] [Related]  

  • 4. Co-trimoxazole in the long-term treatment of pyelonephritis with normal and impaired renal function.
    Denneberg T; Ekberg M; Ericson C; Hanson A
    Scand J Infect Dis Suppl; 1976; (8):61-6. PubMed ID: 1064915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascending pyelonephritis in young rats retards kidney growth.
    Hannerz L; Celsi G; Eklöf AC; Olling S; Wikstad I; Aperia A
    Kidney Int; 1989 May; 35(5):1133-7. PubMed ID: 2671461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Models of urinary infection].
    Prát V; Hatala M; Konícková L; Ritzerfeld W
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):298-305. PubMed ID: 4154600
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on nephrotoxicity of cyclosporin. II. Nephrotoxicity in rats receiving cyclosporin and sulfamethoxazole-trimethoprim].
    Pak K; Tomoyoshi T; Nomura Y; Okabe H
    Hinyokika Kiyo; 1988 Oct; 34(10):1723-31. PubMed ID: 3266713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis.
    Manges AR; Dietrich PS; Riley LW
    Clin Infect Dis; 2004 Feb; 38(3):329-34. PubMed ID: 14727201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Short-term therapy of urinary tract infections with a combination of trimethoprim and sulfamethoxazole].
    Prát V
    Cas Lek Cesk; 1971 Oct; 110(43):1000-3. PubMed ID: 4939127
    [No Abstract]   [Full Text] [Related]  

  • 10. [Failure of peroral trimethoprim/sulfamethoxazole as infection preventive agent in acute lymphatic leukemia].
    Melby K; Kolmannskog S; Flaegstad T
    Tidsskr Nor Laegeforen; 1984 Nov; 104(31):2174-5. PubMed ID: 6397875
    [No Abstract]   [Full Text] [Related]  

  • 11. [Trial of trimedin action on chickens].
    Drumev D; Vangelov S; Pashov D; Iovchev E; Avramova N; Vŭlchanova R
    Vet Med Nauki; 1983; 20(9):87-95. PubMed ID: 6607565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of 3 or 10 days' treatment with nitrofurantoin or cotrimoxazole in urinary infections in children].
    Ruberto U; D'Eufemia P; Chiummariello R; Giardini O
    Pediatr Med Chir; 1984; 6(1):73-5. PubMed ID: 6442413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD; Freeman A; Foxman B
    Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole and trimethoprim alone.
    DuPont HL; Galindo E; Evans DG; Cabada FJ; Sullivan P; Evans DJ
    Gastroenterology; 1983 Jan; 84(1):75-80. PubMed ID: 6336616
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of experimentally induced enterotoxigenic Escherichia coli diarrhea with trimethoprim, trimethoprim-sulfamethoxazole, or placebo.
    Black RE; Levine MM; Clements ML; Cisneros L; Daya V
    Rev Infect Dis; 1982; 4(2):540-5. PubMed ID: 7051247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental septic shock: relative effects of treatment with antibiotics, crystalloid or colloid solution infusions and corticosteroids.
    Ottosson J; Dawidson I; Brandberg A; Eriksson B
    Crit Care Med; 1984 Jul; 12(7):560-4. PubMed ID: 6375964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in trimethoprim levels and its pharmacokinetic parameters in children with chronic renal failure treated with biseptol. I].
    Sieniawska M; Białasik D; Wróblewska-Kałuzewska M; Korniszewska J; Wierzbowska-Lange B; Karczeńska J; Wierzba K
    Pediatr Pol; 1984 Mar; 59(3):177-87. PubMed ID: 6610853
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe thrombocytopenia-hemorrhage due to trimethoprim-sulfamethoxazole: a case report.
    Ahmad S
    W V Med J; 1984 Oct; 80(10):219-20. PubMed ID: 6388160
    [No Abstract]   [Full Text] [Related]  

  • 20. Finding the path of least antimicrobial resistance in pyelonephritis.
    Lautenbach E
    Clin Infect Dis; 2008 Nov; 47(9):1159-61. PubMed ID: 18808350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.